Abstract
The water-soluble, dithio-bis(hydroxymethyl)phosphine ligands (HOH2C)2P(CH2)xS(CH2)3((CH2)4COOH)S(CH2)xP(CH2OH)2 (X = 2 or 3) were complexed with 105Rh. ‘The new 105Rh-complexes were formed in high radiochemical purity by addition of 105RhCl33H2O to an aqueous solution of the appropriate ligand framework. The new complexes were formed as singular chemical species and did not undergo in vitro decomposition for ≤24 hours as indicated by high performance liquid chromatographic analyses. In vivo bio-distribution analyses of the new complexes indicate that the primary mode of excretion is the renal-urinary pathway. Results of this study suggest the potential development of new radiop-harmaceuticals for the treatment of human metastases via conjugation of the new 105Rh-complexes to site-specific biomolecular vectors.